Document Detail

Clear-cell carcinoma of the abdominal wall after cesarean delivery.
MedLine Citation:
PMID:  22825261     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: : Clear-cell carcinoma transformed from an abdominal wall scar is extremely rare; there are only 22 cases reported in literature. Here we report a case of a patient with clear-cell carcinoma of the abdominal wall after cesarean delivery and review the relevant literature.
CASE: : A 49-year-old woman presented with a chief complaint of progressively growing mass of cesarean scar and periodic pain with menstruation for 25 years. Wide surgical resection with clear margins was performed. Clear-cell carcinoma was demonstrated by pathologic examination. The patient underwent six cycles of adjutant chemotherapy postoperatively. The patient remains clinically free of recurrence 8 months after treatment.
CONCLUSION: : Comprehensive treatment consisting of radical surgery combined with adjuvant therapy should be considered for this uncommon condition.
Xiaoyan Li; Jiaxin Yang; Dongyan Cao; Jinghe Lang; Jie Chen; Keng Shen
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  120     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  445-8     Citation Subset:  AIM; IM    
From the Departments of Obstetrics and Gynecology and Pathology, Chinese Academy of Medical Science, Peking Union Medical College Hospital, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tattoo pigment lymphadenopathy mimicking metastasis in vulvar cancer.
Next Document:  Hyperosmolar glucose injection for the treatment of heterotopic ovarian pregnancy.